SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025064
Filing Date
2023-09-01
Accepted
2023-09-01 16:17:18
Documents
13
Period of Report
2023-08-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20230829c_8k.htm   iXBRL 8-K 29598
  Complete submission text file 0001437749-23-025064.txt   165609

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230830.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230830_def.xml EX-101.DEF 11803
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230830_lab.xml EX-101.LAB 15847
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230830_pre.xml EX-101.PRE 12018
7 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230829c_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231232761
SIC: 2834 Pharmaceutical Preparations